News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
For the quarter ended June 2026, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, up 0.5% over the same period last year. EPS came in at $0.21, compared to $0.24 in the year-ago quarter. The reported revenue represents a surprise of +4.17% over the …
Sharemaestro market context Trend signal active 52 weeks +2.9%Avantor, Inc. reported Q2 2026 results with revenue of $1.69 billion, nearly flat year-over-year, and diluted EPS of $0.06, down from $0.09 in the prior year. The company experienced margin pressure and mixed demand, leading to a decline in net income. While VWR Distribution …
Avantor, Inc. reported Q2 2026 adjusted earnings per share of $0.21, surpassing analyst estimates by 10.5%. The company achieved $1.69 billion in revenue, a slight increase from Q2 2025, despite a 0.4% decline in organic revenue due to biopharma and research market headwinds. Avantor …
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Avantor (NYSE:AVTR) Delivers Impressive Q2 CY2026, Stock Soars Life sciences company Avantor (NYSE:AVTR) beat Wall Street's revenue expectations in Q2 CY2026, but sales were flat year on year at $1.69 billion. Its non-GAAP profit of $0.21 per share was 11% above analysts' consensus estimates. …
Sharemaestro market context Trend signal active 52 weeks +2.9%Avantor, Inc. (AVTR) reported its Q2 adjusted EPS at $0.21 per share, surpassing FactSet's estimate of $0.19. This earnings flash highlights the company's financial performance for the second quarter of 2026. The article also mentions Avantor's Q2 revenue of $1.69 billion, exceeding the FactSet …
Avantor, Inc. reported better-than-expected results for the second fiscal quarter of 2026, with net sales of $1,692.3 million. The company's "Revival program" and strong free cash flow generation, used to repay $112.1 million of debt, contributed to the improved performance. Avantor also increased its …
Sharemaestro market context Trend signal active 52 weeks +2.9%This article provides a risk assessment for Avantor Inc (AVTR), detailing its volatility, financial metrics, and investment risks. With a risk assessment score of 5.39, Avantor ranks 78 out of 199 in the Healthcare Equipment & Supplies industry and has a beta of 0.97, …
Avantor Inc (AVTR) has a current financial score of 7.64, placing it 72nd out of 199 in the Healthcare Equipment & Supplies industry. The company's financial status is weak, but its operating efficiency is high, with a recent quarterly revenue of $1.58 billion and …
Avantor Inc (AVTR) shares increased by 5.6% to $12.42, with GuruFocus indicating an undervalued status with a GF Value of $18.43, suggesting a 32.6% upside. Despite this, the company is currently unprofitable and cash-flow-negative, leading to a "possible value trap" label. Insiders have shown …
Avantor, Inc. (AVTR) had approximately 13,496 employees worldwide as of March 2026, marking a 0.5% increase year-over-year. The company's headcount has shown slight fluctuations but maintained stability from 2023 to 2026, with major workforces in the United States, India, and the United Kingdom. Avantor …
Avantor Inc. is set to report its second-quarter earnings, facing skepticism from analysts due to market share losses and pricing pressures, particularly from competitors like Thermo Fisher. The market is keenly watching for signs that the company's turnaround efforts are stabilizing its competitive position …
Earnings To Watch: Avantor (AVTR) Reports Q2 Results Tomorrow Life sciences company Avantor (NYSE:AVTR) will be reporting results this Wednesday before market hours. Here's what investors should know. Avantor beat analysts' revenue expectations last quarter, reporting revenues of $1.58 billion, flat year on year. …
Sharemaestro market context Trend signal active 52 weeks +2.9%This article presents the quarterly and annual cash flow statements for Avantor Inc (AVTR), covering operating, investing, and financing activities from FY2017Q4 to FY2026Q1. It provides detailed financial figures and year-over-year percentage changes for various cash flow components, including net income, capital expenditures, and …
This article provides an earnings forecast for Avantor Inc (AVTR), highlighting its current earnings forecast score of 6.11 and an average analyst price target of $13.00. Based on ratings from 20 analysts, the stock is generally seen as a "Hold." It also presents key …
This article provides a detailed company profile for Avantor Inc (AVTR), a life science tools company. It covers the company's background, business scope including its Laboratory Solutions and Bioscience Production segments, financial data, and market performance. The piece also lists key company information, executive …
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. How Avantor's NuSil collaboration ties into the stock story Avantor (AVTR) drew investor attention after announcing an expanded collaboration between its NuSil brand and …
Sharemaestro market context Trend signal active 52 weeks +2.9%Avantor, Inc. (SWB:AVG) generated a total revenue of 5.58 billion EUR last year. The majority of this revenue, specifically 3.75 billion EUR, came from its top-performing segment, Laboratory Solutions. Geographically, the United States was the greatest contributor, accounting for 2.79 billion EUR of the …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Avantor (NYSE:AVTR), through its NuSil brand, has expanded its collaboration with the Population Council. The partnership focuses on supporting the development of a three-month dapivirine …
Sharemaestro market context Trend signal active 52 weeks +2.9%This article provides a detailed revenue breakdown for Avantor Inc (AVTR) by business segment and geographical region. It shows that proprietary materials & consumables account for 52.64% of revenue, while third-party materials & consumables make up 47.36%. Geographically, the United States contributes 50.05% of …
This article provides a list of Exchange Traded Funds (ETFs) that hold Avantor, Inc. (A2PJN6) stocks, sorted by market value. It details various passive and active ETFs from issuers like BlackRock, Vanguard, and State Street Corp., noting their management style, expense ratio, AUM, price, …
Argus provides a report on Avantor, Inc. (AVTR), a provider of products and services to customers in various industries, including biopharma and healthcare. The report includes an earnings estimate rating and a current price of $11.44 for AVTR stock. The article encourages users to …
Sharemaestro market context Trend signal active 52 weeks +2.9%Avantor Inc (AVTR) shares rose 3.6% to $11.35 and are considered undervalued by approximately 38.4% according to GuruFocus' GF Value™ of $18.43, despite a "possible value trap" warning. The company has a GF Score™ of 61/100, indicating an "above average" rating, with insiders recently …
This article provides a brief overview of Avantor Inc. (AVTR), including its current stock price, market capitalization, key financial metrics, and upcoming earnings date. It also highlights recent news related to AVTR's expected earnings and includes trending discussions about other stocks.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (NYSE:AVTR) concerning corporate wrongdoing. The firm encourages shareholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them to assist with the investigation. This law firm specializes …
The market expects Avantor, Inc. (AVTR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …
Sharemaestro market context Trend signal active 52 weeks +2.9%Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. There …
Sharemaestro market context Trend signal active 52 weeks +2.9%Avantor Inc (AVTR) shares dropped 3.7% to $10.66, trading significantly below its GF Value™ estimate of $18.43, suggesting it is undervalued by 42.2%. Despite the undervaluation, the stock is labeled a potential value trap, warranting caution. Insiders have recently purchased $0.3 million worth of …
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by Avantor, Inc. (AVTR) and its officers/directors. The firm is encouraging investors who purchased Avantor securities before March 5, 2024, and still hold them, to contact them to assist in the …
Avantor, through its subsidiary Avantor Funding, Inc., refinanced €374,208,296.62 in Euro-denominated term loans on July 14, 2026. The new Incremental B-7 Euro Term Loans bear interest at EURIBO Rate + 2.00%, lower than the previous rate of EURIBO Rate + 2.50%, while maintaining a …
Avantor has refinanced €374.2 million of its senior secured Euro-denominated term loans, reducing the interest rate from EURIBO plus 2.50% to EURIBO plus 2.00%. This was achieved through Amendment No. 15 to its Credit Agreement, adding a new Incremental B-7 Euro Term Loans tranche. …
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (AVTR) on behalf of shareholders who purchased securities before March 5, 2024. The investigation concerns possible corporate wrongdoing by Avantor officers and/or directors. The law firm is encouraging affected investors to inquire …
Avantor, Inc. (AVTR) shows strong potential for another earnings beat in its upcoming quarterly report, according to Zacks Equity Research. The company has a history of exceeding earnings estimates, with an average surprise of 5.51% over the past two quarters. This positive outlook is …
Avantor (AVTR) saw its stock surge by 6.2% on Tuesday, closing at $11.21 amidst a broader sector-wide rally in medical instruments and supplies stocks. This increase, which was not driven by company-specific news, appears to be due to institutional buyers rotating capital into the …
Search by ticker symbol or company name and select a result to open its chart.